The Prognostic Impact of In-Hospital Major Bleeding and Recurrence of Myocardial Infarction during Acute Phase after Percutaneous Coronary Intervention for Acute Myocardial Infarction

作者
Yuki Matsuoka,Yohei Sotomi,Shungo Hikoso,Daisaku Nakatani,Katsuki Okada,Tomoharu Dohi,Hirota Kida,Bolrathanak Oeun,Akihiro Sunaga,Taiki Sato,Tetsuhisa Kitamura,Yasuhiko Sakata,Hiroshi Sato,Masatsugu Hori,Issei Komuro,Yasushi Sakata
出处
期刊:Journal of Atherosclerosis and Thrombosis [Japan Atherosclerosis Society]
卷期号:31 (2): 158-170 被引量:3
标识
DOI:10.5551/jat.64274
摘要

AIM: Both recurrent myocardial infarction (ReMI) and bleeding events after acute myocardial infarction (AMI) were reportedly associated with increased mortality. To date, the prognostic impact of these events on subsequent outcomes in East Asians is still unclear. In this study, we aimed to investigate the impact of bleeding or thrombotic events during acute phase on subsequent mortality and time-dependent change of the impact in patients with AMI undergoing percutaneous coronary intervention (PCI). METHOD: We conducted a prospective, multicenter, observational study of patients with AMI (n=12,093). The patients who did not undergo emergent PCI were excluded. In addition, the patients registered before 2003 were excluded because the data of bleeding severity was not obtained. Eligible patients were divided into two groups based on the occurrence of major bleeding within 7 days of PCI, and the same approach was performed for ReMI within 7 days of PCI. The endpoint of this study was all-cause death. We assessed the impact of major bleeding and ReMI, which occurred within 7 days of index PCI, on the subsequent clinical outcomes up to 5 years. RESULTS: A total of 6,769 patients were found to be eligible. All-cause death occurred in 898 (13.3%) patients during a median follow-up period of 1,726 [511-1,840] days. After adjustment for multiple confounders, major bleeding in 7 days from index PCI was independently associated with higher 30-day and 30-day to 1-year mortality (odds ratio [OR]: 2.06 [1.45-2.92] p<0.001, OR: 2.03 [1.28-3.15] p=0.002), whereas ReMI was not (OR: 1.93 [0.92-3.80] p=0.07, OR: 0.81 [0.24-2.03] p=0.68). Major bleeding and ReMI did not affect mortality between 1 and 5 years (hazard ratio [HR]: 1.32 [0.77-2.26] p=0.31, HR: 0.48 [0.12-1.94] p=0.30). CONCLUSION: Major bleeding in 7 days from admission was independently associated with higher 30-day and 1-year mortality but not during 1-5 years. ReMI did not affect mortality in all phases. We should be more concerned about bleeding event during acute phase after PCI.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
难过的耳机完成签到,获得积分10
刚刚
小二郎应助Yuxiao采纳,获得10
刚刚
1秒前
完美世界应助科研通管家采纳,获得20
2秒前
molihuakai应助科研通管家采纳,获得10
2秒前
Hello应助科研通管家采纳,获得10
2秒前
kangkang完成签到,获得积分10
2秒前
深情安青应助科研通管家采纳,获得10
2秒前
赘婿应助科研通管家采纳,获得10
3秒前
李健应助科研通管家采纳,获得10
3秒前
Ava应助科研通管家采纳,获得10
3秒前
cdercder应助科研通管家采纳,获得10
3秒前
williamcrayon发布了新的文献求助10
3秒前
Akim应助科研通管家采纳,获得10
3秒前
3秒前
汉堡包应助旺旺小小贝采纳,获得10
3秒前
能干的鹤发布了新的文献求助10
4秒前
哈哈完成签到 ,获得积分10
5秒前
Ali发布了新的文献求助30
5秒前
小巧吐司发布了新的文献求助10
5秒前
初见有你完成签到,获得积分20
6秒前
att完成签到 ,获得积分10
7秒前
7秒前
东方元语应助时时采纳,获得20
7秒前
8秒前
上官若男应助hay采纳,获得10
8秒前
张泓旭完成签到,获得积分10
8秒前
我是老大应助只如初采纳,获得10
8秒前
冷静映安完成签到,获得积分10
9秒前
9秒前
9秒前
wanci应助学麻了采纳,获得10
9秒前
californiadreami完成签到,获得积分20
10秒前
与光完成签到 ,获得积分10
11秒前
科研通AI6.4应助cc采纳,获得10
12秒前
12秒前
13秒前
14秒前
夜轩岚发布了新的文献求助10
14秒前
和谐凌波发布了新的文献求助10
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
China Pluperfect I: Epistemology of Past and Outside in Chinese Art 520
Matrix Methods in Data Mining and Pattern Recognition Second Edition 510
Governing Growth: Us Industrial Policy from Hamilton to Trump 500
The fast track to determining transfer functions of linear circuits: The student guide 500
The Analytical and Numerical Solution of Electric and Magnetic Fields 500
Synthesis of P-Chiral Phosphine Ligands and Their Applications in Asymmetric Catalysis 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7624935
求助须知:如何正确求助?哪些是违规求助? 9199940
关于积分的说明 19724407
捐赠科研通 7195922
什么是DOI,文献DOI怎么找? 3273608
关于科研通互助平台的介绍 2435791
邀请新用户注册赠送积分活动 2269435